Skip to content
Application 207809
- Type
- ANDA
- Sponsor
- ALVOGEN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | MELPHALAN | MELPHALAN | TABLET;ORAL | 2MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 47781-200 | Melphalan | Melphalan USP, 2 mg | Alvogen Inc. | ANDA | Current |
| 47781-200 | Melphalan | Melphalan USP, 2 mg | Alvogen Inc. | ANDA | Current |
| 47781-200 | Melphalan | Melphalan USP, 2 mg | Alvogen Inc. | ANDA | Current |
| 47781-200 | Melphalan | Melphalan USP, 2 mg | Alvogen Inc. | ANDA | Current |
| 47781-200 | Melphalan | Melphalan USP, 2 mg | Alvogen Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 47670 | ORIG | 2017-03-23 |